Innovative treatments for neurodegenerative diseases

Search documents
Alpha Cognition Inc. Announces Pricing of $35 Million Oversubscribed Public Offering of Common Shares
Businesswireยท 2025-10-01 03:14
Core Viewpoint - Alpha Cognition Inc. has successfully priced an oversubscribed underwritten public offering of 5,600,000 common shares at a price of $6.25 per share, generating gross proceeds of approximately $35.0 million before expenses [1]. Company Summary - The company is a commercial-stage biopharmaceutical firm focused on developing innovative treatments for neurodegenerative diseases [1]. - The offering includes pre-funded warrants in lieu of common shares, indicating strong investor interest and demand for the company's equity [1].